Alexion Pharmaceuticals (NASDAQ:ALXN) reported 3/31/2019 earnings this Morning, coming in at $2.39 per share, beating Wall Street’s estimates of $2.19 per Share. Revenue for the quarter came in at $1.14 billion beating analyst estimates of $1.13 billion
Recent Trading for Alexion Pharmaceuticals (NASDAQ:ALXN)
Shares of Alexion Pharmaceuticals closed the previous trading session at with 131 shares trading hands.